Clinical Trial Update: Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 evaluation of ALT-2074 in adults with Type 2 diabetes and coronary artery disease has completed. The update notes completion of the trial but does not p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• ALT-2074

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Diabetes, Coronary Artery Disease | Phase 2 | Status: COMPLETED